Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARCUS BIOSCIENCES, INC.

(RCUS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about ARCUS BIOSCIENCES, INC.
11/30Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences' An..
BU
11/30Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences? An..
CI
11/24Arcus Biosciences Announces New Employment Inducement Grants
BU
11/22Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conferenc..
BU
11/19Berenberg Bank Adjusts Arcus Biosciences' Price Target to $68 From $60, Maintains Buy R..
MT
11/19Citigroup Adjusts Price Target on Arcus Biosciences to $53 From $42, Reiterates Buy Rat..
MT
11/19Barclays Adjusts Price Target on Arcus Biosciences to $60 From $48, Keeps Overweight Ra..
MT
11/19Wedbush Lifts Price Target on Arcus Biosciences to $67 From $52 After Gilead Opts In to..
MT
11/18Health Care Stocks Ending Little Changed in Quiet Trading
MT
11/18Arcus Biosciences Shares Rally as Gilead Exercises Options
DJ
11/18Gilead Exercises Option to Co-Develop Three Arcus Biosciences Clinical-Stage Cancer Pro..
MT
11/18SVB Leerink Adjusts Price Target on Arcus Biosciences to $100 From $68, Maintains Outpe..
MT
11/18Gilead Exercises Options to Three Arcus Biosciences Programs
DJ
11/18ARCUS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
11/18Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Re..
BU
11/09Arcus Biosciences Announces New Employment Inducement Grants
BU
11/09Mizuho Securities Adjusts Arcus Biosciences' Price Target to $51 From $43, Reiterates B..
MT
11/09Barclays Adjusts Price Target on Arcus Biosciences to $48 From $45, Keeps Overweight Ra..
MT
11/08Arcus Biosciences Swings to Loss in Q3 As Revenue Drops
MT
11/08Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update o..
PU
11/08Arcus Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
11/08ARCUS BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
11/08Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q3 Revenue $9.46M, vs. Street Est of $9.3..
MT
11/08Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update o..
BU
11/02Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Hig..
BU
10/26Arcus Biosciences Announces New Employment Inducement Grants
BU
10/11ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
09/27ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
09/22INSIDER SELL : Arcus Biosciences
MT
09/17ARCUS BIOSCIENCES : Thinking about buying stock in Corvus Pharmaceuticals, AbCellera Biolo..
PR
09/09ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
09/01ARCUS BIOSCIENCES : to Participate at Upcoming Investor Conferences
BU
08/24ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
08/11ARCUS BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/11Arcus Biosciences, Inc. Announces Board Changes
CI
08/10ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
08/06ARCUS BIOSCIENCES : SVB Leerink Adjusts Price Target on Arcus Biosciences to $68 From $63,..
MT
08/05ARCUS BIOSCIENCES : Earnings Flash (RCUS) ARCUS BIOSCIENCES Reports Q2 Revenue $9.5M, vs. ..
MT
08/05ARCUS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Result..
AQ
08/05ARCUS BIOSCIENCES : Reports Second Quarter 2021 Financial Results and Provides Operational..
BU
08/05ARCUS BIOSCIENCES, INC. : Results of Operations and Financial Condition, Change in Directo..
AQ
08/05Arcus Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, ..
CI
08/05Arcus Biosciences, Inc. Appoints Nicole Lambert to the Board as Class II Director
CI
08/04ARCUS BIOSCIENCES : to Participate at the 2021 Wedbush PacGrow Virtual Healthcare Conferen..
BU
07/29ARCUS BIOSCIENCES : to Report Second Quarter 2021 Financial Results & Recent Corporate Hig..
BU
07/26ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
07/20ARCUS BIOSCIENCES : Chief Medical Officer Resigns to Join Gilead's Oncology Team
MT
07/19ARCUS BIOSCIENCES : CHIEF MEDICAL OFFICER TRANSITIONS TO ROLE AT GILEAD SCIENCES (Form 8-K..
PU
07/19ARCUS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Regulation FD Disclos..
AQ
07/19Bill Grossman, Arcus Biosciences, Inc.'s Chief Medical Officer, Resigns
CI
07/12ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) added to Russell Small Cap Comp Value Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) dropped from Russell 3000E Growth Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) added to Russell 3000E Value Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) dropped from Russell 2500 Growth Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) added to Russell 3000 Value Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) dropped from Russell 3000 Growth Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) added to Russell 2500 Value Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) dropped from Russell Small Cap Comp Growth Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) dropped from Russell 2000 Growth Index
CI
06/25ARCUS BIOSCIENCES, INC.(NYSE : RCUS) added to Russell 2000 Value Index
CI
06/24ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
06/24ARCUS BIOSCIENCES : Climbs 15% on 'Encouraging' Lung Cancer Trial Data
MT
06/24ARCUS BIOSCIENCES : SVB Leerink Adjusts Price Target on Arcus Biosciences to $63 From $53,..
MT
06/24Wall Street Set For Higher Open, Jobless Claims Tick Down
MT
06/24ARCUS BIOSCIENCES : Thinking about buying stock in Arcus Biosciences, Capricor Therapeutic..
PR
06/23ARCUS BIOSCIENCES' : Drug Combo in Lung Cancer Trial Shows 'Encouraging' Activity
MT
06/23ARCUS BIOSCIENCES : Anti-TIGIT Domvanalimab-Based Combinations Showed Encouraging Clinical..
BU
06/23Arcus Biosciences, Inc. Announces Anti-TIGIT Domvanalimab-Based Combinations Clinical A..
CI
06/21INSIDER TRENDS : Arcus Biosciences Insider Sale Scales Back 90-Days of Buys
MT
06/21INSIDER TRENDS : Insider Sale at Arcus Biosciences Slowing 90-Days of Buying
MT
06/21INSIDER TRENDS : Insider Disposition Eases Back 90-Day Buy Trend at Arcus Biosciences
MT
06/21INSIDER TRENDS : 90-Days of Insider Buying at Arcus Biosciences Interrupted with Share Dis..
MT
06/09ARCUS BIOSCIENCES : Announces New Employment Inducement Grants
BU
06/07ARCUS BIOSCIENCES : AMENDED COMPENSATION PROGRAM FOR NON-EMPLOYEE DIRECTORS (Form 8-K)
PU
1  2  3  4  5Next
Upcoming event on ARCUS BIOSCIENCES, INC.